Guocai Zhong

Emmune, Inc

$767,738

Attributed

$917,738

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $617.7K · FY2018–25

$1M$750K$500K$250K$0

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$917,738 · 2

By mechanism

R01$617,738 · 1

R43$300,000 · 1

Top collaborators

Michael David Alpert1 shared

Most similar at Emmune, Inc

Same institution · by research overlap

Michael David Alpert$15,939,345

Others in their field

Other Emerging Leaders on “Ace2”

Hongpeng Jia · Johns Hopkins University$3,826,476
Ya-Wen Chen · University Of Southern California$3,181,082
Yogesh K Gupta · University Of Texas Hlth Science Center$3,161,127
Aaron Gregory Schmidt · Boston Children'S Hospital$2,740,403
Megan A O'Connor · University Of Washington$2,375,036
Ricardo Rajsbaum · University Of Texas Med Br Galveston$2,360,403

Research focus

Ace2Adeno-Associated Viral VectorAdenovirus Mediated DeliveryAdverse EffectsAdverse EventAnemiaAnimalsAntibioticsBiologicalBiological ProductsCatalytic RnaCell Culture TechniquesChronicCirculationCommunicable DiseasesCoronavirusCovid-19CytokineDevicesDisease ProgressionDoseDuchenne Muscular DystrophyEbola3&Apos

Grant awards (2)

Synthetic RNA Switch-Based Temporal and Dose Control of in Vivo Gene Therapies$617,738

R01 · FY2025 · EB · contact PI

Cpf1-mediated inactivation of an AAV transgene$300,000

R43 · FY2018 · AI